HRT Financial sells $2,211 in Profusa (PFSA) shares

HRT Financial LP, an owner and director of Profusa Inc., recently sold 2,280 shares of the company's common stock on August 11, 2026, for a total of $2,211, at $0.97 per share. Earlier on August 10, 2026, the firm bought 4,016 shares for $3,791, at $0.944 per share. Consequently, HRT Financial LP now owns 111,024 shares of Profusa directly.

The stock trades at $0.90, down about 100% year-to-date. Despite this decline, InvestingPro analysis suggests the stock is slightly undervalued, with the RSI indicating it is in oversold territory. The platform provides 13 exclusive tips for PFSA investors. HRT Financial LP is based in New York, NY. Profusa Inc. recently approved several key proposals at its annual meeting, including the acquisition of the PanOmics multi-omics diagnostics platform from BioInsights LLC and a 1-for-25 reverse stock split to meet Nasdaq listing compliance.

Shareholder Lauren Chung was elected as a Class I director to serve until the 2029 annual meeting. Additionally, Profusa submitted a response package to GMED, its European Notified Body, for regulatory review of its Lumee Oxygen Platform.